Effect of Modification of the N-Terminal Region of Semax on the Expression of Nootropic Effect of Semax Analogs
- 37 Downloads
A comparative study of nootropic activity of semax (MEHFPGP), an analog of ACTH4–10, and some of its derivatives, in which the N-terminal methionine was modified or substituted with other amino acid residues, was performed. The effect of these peptides on learning of albino rats in tests with positive (food) and negative (pain) reinforcement was studied. In the case of modification of methionine by attachment of the gluconic-acid residue or substitution of methionine with lysine, the nootropic effect of the peptide was retained. The substitution of methionine with tryptophan or serine resulted in a decrease in the nootropic activity. The substitution of methionine with glycine, threonine, or alanine caused a complete loss of the nootropic activity of the peptide. Therefore, the amino acid residue located at position 1 of the heptapeptide analog semax, plays a key role in retaining the nootropic effects of the peptide and determines the degree of their expression.
KeywordsPeptide Glycine Serine Lysine Alanine
Unable to display preview. Download preview PDF.
- Ashmarin, I.P., Nezavibatko, V.N., Levitskaya, N.G., Koshelev, V.B., and Kamensky, A.A., Design and Investigation of An ACTH4–10 Analog Lacking D-Amino Acids and Hydrophobic Radicals, Neurosci. Res. Commun., 1995, vol. 16, no.2, pp. 105–112.Google Scholar
- Ashmarin, I.P., Nezavibat’ko, V.N., Myasoedov, N.F., Kamenskii, A.A., Grivennikov, I.A., Ponomareva-Stepnaya, M.A., Andreeva, L.A., Kaplan, A.Ya., Koshelev, V.B., and Ryasina, T.V., Nootropnyi analog adrenokortikotropina 4–10—semaks (15-letnii opyt razrabotki i izucheniya) (Nootropic Analog of Adrenocorticotropic Hormone 4–10, Semax: Fifteen-year Experience of Development and Study), Zh. Vyssh. Nerv. Deyat., 1997, vol. 47, pp. 426–436.Google Scholar
- Glazova, N.Yu., Levitskaya, N.G., Andreeva, L.A., Kamenskii, A.A., and Myasoedov, N.F., Nootropnye effekty novogo analoga fragmenta AKTG5–10-geksapeptida AKTG5–7-PGP (Nootropic Effects of the Hexapeptide ACTH5–7-PGP, a Novel Analog of the ACTH5–10 Fragment), Dokl. Akad. Nauk, 1999, vol. 367, no.1, pp. 137–140.PubMedGoogle Scholar
- Levitskaya, N.G., Sebentsova, E.A., Glazova, N.Yu., Voskresenskaya, O.G., Andreeva, L.A., Alfeeva, L.Yu., Kamenskii, A.A., and Myasoedov, N.F., Issledovanie neirotropnoi aktivnosti produktov fermentativnoi degradatsii semaksa, Dokl. Akad. Nauk, 2000, vol. 372, no.2, pp. 268–271.Google Scholar
- Vinogradov, V.M., Medvedev, V.I., Grechko, A.T., Bakharev, V.D., and Ponomareva-Stepnaya, M.A., Vliyanie na povedencheskuyu aktivnost’ krys fragmentov AKTG i vazopressina (Effect of ACTH Fragments and Vasopressin on Behavioral Activity of Rats), Fiziol. Zh. SSSR im. I.M. Sechenova, 1980, vol. 66, pp. 409–415.PubMedGoogle Scholar
- Zamyatnin, A.A., Spetsializirovannyi bank dannykh EROP-Moscow o regulyatornykh oligopeptidakh s Internet-dostupom (Specialized Databank EROP-Moscow with an Internet Access on Regulatory Oligopeptides), in Tez. dokladov Rossiiskogo simpoziuma po khimii i biologii peptidov (Russian Symposium on Chemistry and Biology of Peptides, Abstracts of Papers), Moscow, 2003.Google Scholar